A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
The recent Ebola virus (EBOV) epidemic highlighted the need for effective vaccines and therapeutics to limit and prevent outbreaks. Host antibodies against EBOV are critical for controlling disease, and recombinant monoclonal antibodies (mAbs) can protect from infection. However, antibodies mediate...
Main Authors: | Yu, Wen-Han, Das, Jishnu, Lauffenburger, Douglas A, Alter, Galit |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2020
|
Online Access: | https://hdl.handle.net/1721.1/126177 |
Similar Items
-
Fc Glycan-Mediated Regulation of Placental Antibody Transfer
by: Jennewein, Madeleine F, et al.
Published: (2021) -
Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
by: Rodriguez-Martinez, Luis Mario, et al.
Published: (2015) -
In silico-based vaccine design against Ebola virus glycoprotein
by: Dash, R., et al.
Published: (2017) -
Monoclonal antibodies: a review of therapeutic applications and future prospects
by: Mahmuda, Aliyu, et al.
Published: (2017) -
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
by: Lofano, Giuseppe, et al.
Published: (2020)